ROCKVILLE, Md., March 7 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Partnering for Global Health Forum event at 3:15 p.m. EST on March 11, 2008 in Washington D.C. Dr. Singhvi will provide an overview of the company's strategy and progress in the area of vaccine development to protect against H5N1 pandemic influenza, seasonal influenza and other viral diseases.
The Partnering for Global Health Forum is organized by BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) and is sponsored by the Bill & Melinda Gates Foundation.
Novavax Inc. is a clinical stage vaccine company committed to leading the global fight against infectious disease by creating novel, highly potent vaccines that are safer and more effective than current preventive options. Using the company's proprietary virus-like particle (VLP) and Novasome(R) adjuvant technologies, Novavax is developing vaccines to protect against H5N1 pandemic influenza, seasonal flu and other viral diseases. Novavax's particulate vaccines closely match disease-causing viruses while lacking the genetic material to cause disease, which provides potential for greater immune protection at lower doses than current vaccines. With an exclusive portable manufacturing system that allows for rapid mass-production of vaccines, Novavax is uniquely positioned to meet global public health needs.
|SOURCE Novavax, Inc.|
Copyright©2008 PR Newswire.
All rights reserved